Deals
Embassy Group, one of India’s largest real estate conglomerates, has joined proptech investor, Pi Labs, as a limited partner (LP) in its current Fund 3.
The investment will support Embassy Group’s commitment to the transformation of the real estate sector through innovative technology, drawing on synergies from Pi Labs proptech ecosystem.
By participating in Pi Labs Fund 3 as an LP, Embassy Group is positioning itself to take the industry forward in technology adoption. Pi Labs is Europe’s most active proptech VC, with over 55 investments in its portfolio. The strategic investment by Embassy Group will form a gateway
Emmes, a global, full-service Clinical Research Organisation (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, has acquired Orphan Reach, a CRO specialised in clinical research related to rare diseases.
Financial terms of the transaction have not been disclosed.
This marks Emmes’ second acquisition since Behrman’s investment in 2019 and builds on its recent acquisition of Neox SRO (Neox) in December 2020. Founded nearly 20 years ago, Orphan Reach has its headquarters in the United Kingdom and offices in Ireland, Germany, India, Canada, and the United States. The acquisition expands
BV Investment Partners (BV), a middle-market private equity firm focused on the tech-enabled business services, software and IT services sectors, has made a majority investment in Resource Innovations, a provider of demand-side management, energy efficiency, and energy consulting services.
Concurrent with BV’s investment, Resource Innovations is combining with energy software and consulting firm Nexant, Inc, to provide energy and software solutions for utilities and commercial, industrial, and residential energy consumers.
Headquartered in the San Francisco Bay Area, CA, Resource Innovations’ services to utilities in the US include portfolio administration, program implementation, public sector outreach, planning & design services
Praetura Group, the Manchester-based debt and equity capital provider to northern SMEs, provided more than GBP75 million of funding to SMEs in the first quarter of 2021, with demand continuing to rise.
The lending division of the Praetura Group, which comprises Praetura Commercial Finance and the Praetura Asset Finance Group, has seen its highest quarterly lending levels since it was founded in 2011.
Praetura Commercial Finance, which provides asset-based lending (ABL) solutions to SMEs, has enjoyed its best quarter to date, having completed transactions totalling GBP50.5 million in Q1 2021. All of these deals were management buyouts (MBOs) and
Omnio, a Banking-as-a-Service specialist, has closed a EUR30 million funding round led by pan-European venture fund GrayBella Capital.
Omniom a high-growth pre-IPO banking infrastructure leader based in London, will pursue its organic Pan-European growth strategy including selected acquisitions in its core markets.
Omnio offers a white-label, highly scalable service and is the secret ingredient that transforms retail banking. Omnio empowers smaller financial institutions, including credit unions and building societies to compete vigorously with their larger, tech-enabled rivals, and large brand driven corporations (non-banks) to deliver state-of-the art financial and loyalty products as part of their digital ecosystem. This is disrupting
Private equity firm SFW Capital Partners (SFW) has completed a majority recapitalisation of Granite River Labs (GRL), a specialist in test and certification services and automated test solutions for digital connectivity and charging technologies.
Co-founders Johnson Tan and Quintin Anderson will continue to lead the business and remain significant shareholders. Terms of the private transaction have not been disclosed.
Santa Clara, California-based GRL specialises in helping product developers implement the latest connectivity and charging interfaces – such as USB, Qi wireless charging, Ethernet, and PCI Express – in a rapidly expanding universe of connected devices and applications, including consumer
By Purva Aggarwal – Warburg Pincus has invested USD110 million into a Series C round for New York-based healthcare tech company Aetion.
This round is the latest in a string of similar investments within the health tech space for Warburg Pincus. The global growth equity PE group has poured in excess of USD12 billion and USD22 billion to date into health care and technology companies respectively, including Alignment Healthcare, Experity, Intelligent Medical Objects, Modernizing Medicine, and Outset Medical.
B Capital and Foresite Capital, as well as existing supporters New Enterprise Associates (NEA) and Flare Capital Partners joined the fundraise,
Money Alive, a regulatory technology business based in Bedford, is set for further growth following a GBP749,000 financial investment from Foresight Group (Foresight) using equity finance from the Midlands Engine Investment Fund (MEIF) as part of a GBP1 million funding round together with a number of private investors.
Founded by CEO Andy Kirby, Money Alive launched its first commercial product in 2018. Its proprietary video engagement platform is licensed to financial advisers, product providers and employee benefit consultants to provide their clients, policy holders and members with engaging, accredited and impartial information using Money Alive’s interactive video experiences. The firm
Eurazeo is to sell 49 per cent of its stake in Trader Interactive, a provider of online advertising & marketing solutions to the powersports, recreational vehicle, commercial truck & equipment industries based in Virginia (USA), to carsales an online automotive advertising platform in Australia with a growing presence in Latin America and Asia.
Internationally, carsales operates several marketplaces across both the automotive and specialty vehicle segments with leading properties such as demotores.com in Argentina and EnCar in South Korea.
Under this agreement, Trader Interactive is valued at USD1.625 billion corresponding to 26.5-times CY 2020 Adjusted EBITDA. With this operation,
Huma Therapeutics Limited has completed its latest funding round with financing of approximately USD130 million. The investment will scale Huma’s modular platform which can power digital ‘hospitals at home’ nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials.
Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
